NO20004405L - Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati - Google Patents

Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Info

Publication number
NO20004405L
NO20004405L NO20004405A NO20004405A NO20004405L NO 20004405 L NO20004405 L NO 20004405L NO 20004405 A NO20004405 A NO 20004405A NO 20004405 A NO20004405 A NO 20004405A NO 20004405 L NO20004405 L NO 20004405L
Authority
NO
Norway
Prior art keywords
carbon atoms
prophylaxis
pharmaceutical composition
ocular
alkyl group
Prior art date
Application number
NO20004405A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004405D0 (no
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO20004405D0 publication Critical patent/NO20004405D0/no
Publication of NO20004405L publication Critical patent/NO20004405L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
NO20004405A 1998-03-05 2000-09-04 Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati NO20004405L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5362498 1998-03-05
PCT/JP1999/001031 WO1999044624A2 (en) 1998-03-05 1999-03-03 Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy

Publications (2)

Publication Number Publication Date
NO20004405D0 NO20004405D0 (no) 2000-09-04
NO20004405L true NO20004405L (no) 2000-11-03

Family

ID=12948075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004405A NO20004405L (no) 1998-03-05 2000-09-04 Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati

Country Status (17)

Country Link
US (1) US6423691B1 (ja)
EP (2) EP1504760B1 (ja)
JP (1) JP4422894B2 (ja)
KR (1) KR20010041605A (ja)
CN (1) CN1298304A (ja)
AR (1) AR018576A1 (ja)
AT (2) ATE400277T1 (ja)
AU (1) AU2745599A (ja)
BR (1) BR9908566A (ja)
CA (1) CA2322854A1 (ja)
DE (2) DE69939075D1 (ja)
HU (1) HUP0101733A3 (ja)
ID (1) ID27083A (ja)
NO (1) NO20004405L (ja)
PL (1) PL343412A1 (ja)
WO (1) WO1999044624A2 (ja)
ZA (1) ZA991749B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572833B2 (en) * 2000-10-26 2009-08-11 Senju Pharmaceutical Co., Ltd. Drug composition comprising dipeptidyl aldehyde derivative
DE60330038D1 (de) * 2002-07-22 2009-12-24 Senju Pharma Co Neue alpha-ketoamidderivate und deren verwendung
DE60330685D1 (de) 2002-09-19 2010-02-04 Koninkl Philips Electronics Nv Optischer schalter auf basis von elektrobenetzung
WO2004060373A1 (ja) * 2002-12-27 2004-07-22 Santen Pharmaceutical Co., Ltd. 滲出型加齢黄斑変性治療剤
TWI695723B (zh) 2009-05-29 2020-06-11 美商沛爾醫療股份有限公司 用於經由呼吸道輸送活性劑的組成物以及相關方法與系統
US20120065793A1 (en) 2010-02-25 2012-03-15 Kaji Mitsuru Demand and supply control apparatus, demand and supply control method, and program
JP5823484B2 (ja) 2010-07-14 2015-11-25 千寿製薬株式会社 α―ケトアミド誘導体固体分散体
RU2452436C1 (ru) * 2011-01-31 2012-06-10 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" Способ лечения атрофии зрительного нерва сосудистого генеза
JPWO2015125941A1 (ja) * 2014-02-21 2017-03-30 株式会社ヘリオス 眼疾患治療剤、そのスクリーニング方法または網膜色素上皮細胞移植に伴う拒絶反応の予測方法
AU2016320905B2 (en) 2015-09-11 2021-10-07 The Schepens Eye Research Institute, Inc. Compositions and methods for prevention and treatment of corneal haze and scarring
US11439608B2 (en) 2017-09-25 2022-09-13 Qun Lu Roles of modulators of intersectin-CDC42 signaling in Alzheimer's disease
PL424452A1 (pl) * 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504938A3 (en) * 1991-03-22 1993-04-14 Suntory Limited Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
JP3599287B2 (ja) * 1993-04-28 2004-12-08 三菱化学株式会社 スルホンアミド誘導体
EP0731107A1 (en) * 1995-02-13 1996-09-11 Takeda Chemical Industries, Ltd. Production of aldehyde derivatives
ES2193615T3 (es) * 1995-10-25 2003-11-01 Senju Pharma Co .nhibidor de la angiogenesis.
ATE377006T1 (de) * 1995-11-28 2007-11-15 Cephalon Inc Aus d-aminosäuren abgeleitete cystein- und serinproteasehemmer
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung

Also Published As

Publication number Publication date
ATE296635T1 (de) 2005-06-15
HUP0101733A2 (hu) 2001-11-28
DE69939075D1 (de) 2008-08-21
KR20010041605A (ko) 2001-05-25
EP1504760A1 (en) 2005-02-09
EP1058553B1 (en) 2005-06-01
PL343412A1 (en) 2001-08-13
DE69925578D1 (de) 2005-07-07
JP4422894B2 (ja) 2010-02-24
WO1999044624A3 (en) 1999-10-21
NO20004405D0 (no) 2000-09-04
ID27083A (id) 2001-02-22
US6423691B1 (en) 2002-07-23
ATE400277T1 (de) 2008-07-15
CA2322854A1 (en) 1999-09-10
CN1298304A (zh) 2001-06-06
BR9908566A (pt) 2000-11-21
HUP0101733A3 (en) 2001-12-28
AR018576A1 (es) 2001-11-28
AU2745599A (en) 1999-09-20
EP1504760B1 (en) 2008-07-09
DE69925578T2 (de) 2006-04-27
ZA991749B (en) 1999-09-16
WO1999044624A2 (en) 1999-09-10
JP2002505297A (ja) 2002-02-19
EP1058553A2 (en) 2000-12-13

Similar Documents

Publication Publication Date Title
NO20062370L (no) Amidderivater
ATE223378T1 (de) Prolineamid-derivate
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
NO20004405L (no) Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati
DE60315674D1 (de) Neue imidazopyridine und ihre verwendung
NO20051263L (no) Ny anvendelse av benzotiazolderivater
YU49443B (sh) Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija
NO20054855L (no) Preventiv/hjelpemiddel for retinal nervesykdommer inneholdende alkyleterderivater eller salter derav
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
ATE319458T1 (de) Medizinische zusammensetzungen zur behandlung von augenerkrankungen
ATE318799T1 (de) Pyrrolderivate und medizinische zubereitung.
BR0015195A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas
HUP0202745A2 (hu) Profilaktikus és terápiás szerek szembetegségek kezelésére
IS8096A (is) Notkun karbamasepínafleiða til að meðhöndla órósemi í sjúklingum er þjást af vitglöpum
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
BR9910637A (pt) Composto da série da benzofuroxana usada para distúrbios cardiovasculares, processos para a preparação dos derivados de benzofuroxana, e para a preparação de 5 (6)-[(2,3-diidróxi propilóxi)-carbonil] benzofuroxana, uso do composto, composição farmacêutica, processo para a preparação da mesma, e, processo para o tratamento de um mamìfero, incluindo um ser humano, de doença cardìacas da coronária.
ATE284684T1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
CA2202904A1 (en) Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
NO980058L (no) Opthalmiske preparater
DE69518706D1 (de) Verwendung von Diphenylethanderivaten zur Herstellung eines Arzneimittels zur Behandlung von Glaukom
DE69713648T2 (de) Benzopyranderivate und ihre Verwendung zur Behandlung von Herzkrankheiten
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse
DE3884878D1 (de) Uricosuretische Zusammensetzung.
HUP0202011A2 (hu) Új ciklusos alfa-amino-gamma-hidroxiamid vegyületek, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application